Understanding the
chemistry of biology

Our in-house expertise centers around understanding and integrating the chemistry and biology of novel antimicrobial treatments from early research stages until entry into the clinic.

We have a diversity of in-house scientific know how including computational and analytical chemistry, medicinal chemistry, organic chemistry, pharmacology, clinical drug development, microbiology, molecular biology, cell biology and biochemistry along with a strong flare for doing things in a different way. It’s the “what if?” factor. In a word, innovation.

Our scientists have well-honed skill in designing, developing, carrying out and validating assays. We know and understand how to work with a range of small molecules, sugars, enzymes and synthetic chemistries and have been able to synthesise and derivatise molecules of interest during lead optimisation processes.  

In-house facilities and technologies include a bespoke Class II microbiology laboratory, a cell biology laboratory, analytical and R&D laboratories, in-house genomics and confocal imaging facilities and a range of separation, drying and analytical technologies.

We also have the facilities and proven skill that allows us to scale up CMC production in-house or so that we can try out the ideas that we have generated in our laboratories in closer to life contexts.

This combination of scientific knowledge, experience and infrastructure means we can conceptualise, produce and trial R&D solutions and assets being development in-house prior to developing them further with external partners through collaborative or trade deals.

 

Our Network and Partnerships

Our networks and partnerships

Understanding the chemistry of biology

Our in-house expertise centers around understanding and integrating the chemistry and biology of novel antimicrobial treatments from early research stages until entry into the clinic.

We have a diversity of in-house scientific know how including computational and analytical chemistry, medicinal chemistry, organic chemistry, pharmacology, clinical drug development, microbiology, molecular biology, cell biology and biochemistry along with a strong flare for doing things in a different way. It’s the “what if?” factor. In a word, innovation.

Our scientists have well-honed skill in designing, developing, carrying out and validating assays. We know and understand how to work with a range of small molecules, sugars, enzymes and synthetic chemistries and have been able to synthesise and derivatise molecules of interest during lead optimisation processes.  

In-house facilities and technologies include a bespoke Class II microbiology laboratory, a cell biology laboratory, analytical and R&D laboratories, in-house genomics and confocal imaging facilities and a range of separation, drying and analytical technologies.

We also have the facilities and proven skill that allows us to scale up CMC production in-house or so that we can try out the ideas that we have generated in our laboratories in closer to life contexts.

This combination of scientific knowledge, experience and infrastructure means we can conceptualise, produce and trial R&D solutions and assets being development in-house prior to developing them further with external partners through collaborative or trade deals.

 

Our Network and Partnerships

Our networks and partnerships